Hydroxyl PEG Succinimidyl Propionate, commonly referred to as PEG-SPA, is a polyethylene glycol (PEG) derivative that contains a succinimidyl propionate functional group (-SPA) attached to a hydroxyl group (-OH) of the PEG chain. The succinimidyl propionate group is known for its ability to react with primary amines of biomolecules, enabling the covalent attachment of drugs or other bioactive molecules to the PEG chain.
PEG-SPA has been extensively utilized in pharmaceutical research and development for the development of novel drug delivery systems. Its unique chemical properties allow for the conjugation of therapeutic agents, such as proteins, peptides, or small molecules, to the PEG chain via stable amide bonds. This conjugation enhances the pharmacokinetic and pharmacodynamic properties of the drug, leading to improved efficacy, reduced toxicity, and prolonged circulation time in the bloodstream.
In addition to its use in drug delivery systems, PEG-SPA has also been employed in the development of diagnostic and imaging agents. It can be used to attach various imaging agents, such as fluorescent dyes, radioactive isotopes, or magnetic nanoparticles, to biomolecules, allowing for the visualization and detection of specific targets in vivo.
Hydroxyl PEG Succinimidyl Propionate
|AP14593||Hydroxyl PEG Succinimidyl Propionate, MW 3.5K||3500||≥95%||Pricing|
|AP14594||HO-PEG-SPA, MW 5K||5000||≥95%||Pricing|